PDL, Biogen Idec's Phase II Deal Valued At Up To $800M

Protein Design Labs Inc. nailed down the whopper deal of the year so far with Biogen Idec Inc., which is paying $40 million up front, buying $100 million in equity, and promising up to $660 million in milestones related to three Phase II compounds. (BioWorld Today)